jasminum officinale flower/leaf extract est-il sûr pendant la grossesse ?
No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
Pregnancy-safe products containing jasminum officinale flower/leaf extract










Related ingredients
Frequently asked questions
- jasminum officinale flower/leaf extract est-il sûr pendant la grossesse ?
- No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
- jasminum officinale flower/leaf extract est-il sûr pendant l'allaitement ?
- No evidence of reproductive/ developmental toxicity or lactation transfer reported in SCCS/CIR or peer‑reviewed literature for this extract. Systemic absorption from typical topical cosmetic use is low but measurable, so breastfeeding exposure is scored as low (1). Sources: CIR (no specific restriction), CosIng, PubChem.
- jasminum officinale flower/leaf extract est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental hazards identified. Mechanistic data lacking. Because infants (0–3 yr) have higher dermal absorption and surface‑area‑to‑weight ratio, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Note: this does not indicate intrinsic reproductive hazard but reflects higher potential exposure through immature skin. Sources: CosIng, PubChem, general toxicological principles on infant skin permeability.
- Comment VeriMom évalue-t-il jasminum officinale flower/leaf extract ?
- VeriMom évalue jasminum officinale flower/leaf extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à jasminum officinale flower/leaf extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à jasminum officinale flower/leaf extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.